Journal article

Publication year: 2014

Pages: 488-499

Journal: The Lancet Diabetes & Endocrinology

Volume number: 2

Issue number: 6

ISSN: 2213-8587

DOI Link: https://doi.org/10.1016/S2213-8587(13)70176-1

Publisher: Elsevier

Abstract: 
Gestational diabetes is characterised by glucose intolerance with onset or first recognition during pregnancy. The disease shows facets of the metabolic syndrome including obesity, insulin resistance, and dyslipidaemia. Adipokines are a group of proteins secreted from adipocytes, which are dysregulated in obesity and contribute to metabolic and vascular complications. Recent studies have assessed the role of various adipokines including leptin, adiponectin, tumour necrosis factor alpha (TNF alpha), adipocyte fatty acid-binding protein (AFABP), retinol-binding protein 4 (RBP4), resistin, NAMPT, SERPINA12, chemerin, progranulin, FGF-21, TIMP1, LCN2, AZGP1, apelin (APLN), and omentin in gestational diabetes. This Review provides an overview of these key adipokines, their regulation in, and potential contribution to gestational diabetes. Based on the evidence so far, the adipokines adiponectin, leptin, TNF alpha, and AFABP seem to be the most probable candidates involved in the pathophysiology of gestational diabetes.

Harvard Citation style: Fasshauer, M., Blüher, M. and Stumvoll, M. (2014) Adipokines in gestational diabetes, The Lancet Diabetes & Endocrinology, 2(6), pp. 488-499. https://doi.org/10.1016/S2213-8587(13)70176-1

APA Citation style: Fasshauer, M., Blüher, M., & Stumvoll, M. (2014). Adipokines in gestational diabetes. The Lancet Diabetes & Endocrinology. 2(6), 488-499. https://doi.org/10.1016/S2213-8587(13)70176-1